MBC Board of Directors

Chair Michael D. Webb Ascent Therapeutics, Inc.
Vice-Chair Mark Leuchtenberger Targanta Pharmaceuticals
Treasurer Michael W. O'Hara Deloitte
Clerk Glenn Batchelder BIND BioSciences, Inc.
Immediate Past Chair Una Ryan AVANT Immunotherapeutics, Inc.

Board Members
  Mark R. Bamforth Genzyme Corporation
  Geoffrey F. Cox GTC Biotherapeutics, Inc.
  Erroll De Souza Archemix Corporation
  Jeffrey J. Elton Novartis Institutes for BioMedical Research, Inc.
  Fereydoun Firouz Serono, Inc.
  Steven C. Gilman Cubist Pharmaceuticals
  Scott Gillis Formerly of NUCRYST Pharmaceuticals
  John K. Hennessy AstraZeneca Pharmaceuticals, LP
  Timothy Hunt Biogen Idec
  Michael E. Kamarck Wyeth Biotech Technical Operations and Product Supply
  Edwin M. Kania, Jr. Flagship Ventures
  Laurie Bartlett Keating Millenium Pharmaceuticals
  Judy Ozbun New England Healthcare Institute
  David J. McLachlan Emeritus
  Steven G. Richter MicroTest Laboratories, Inc.
  Amit Sachdev Vertex Pharmaceuticals, Inc.
  Frank Thomas Critical Therapeutics, Inc.
  Lawrence S. Wittenberg Goodwin Procter LLP

Counsel
Legislative William P. McDermott McDermott, Quilty & Miller LLP
Communication Robert Gottlieb Feinstein Kean Healthcare

Also see our senior staff.